Contract success for Ascribe

  • 9 May 2006

 Health IT software company Ascribe has announced it has been awarded several new contracts in its pharmacy and primary and unscheduled care divisions, including one for a ‘super surgery’ planned for Liverpool this summer.

Ascribe will be supplying a bespoke web-based healthcare IT system featuring both clinical and administrative features to Assura, a subsidiary of the Medical Property Investment Fund and the private firm that will be running the service. The contract will be sole-supplier.

In Scotland, Ascribe will also be piloting its medicines management software across three acute wards in Tayside, as well as installing it in sites in County Durham and Darlington.

Sites in Wales and Northern Ireland will also be receiving Accident and Emergency systems, along with two sites in Southport & Ormskirk and four sites in Barking, Havering & Redbridge NHS Trust.

Steven Critchlow, executive chairman of Ascribe, said: "We are pleased to be able to report our continued success with many new customers ordering and ‘going live’ across the Group. Our solutions continue to win new business and find new applications to deliver health-improving systems to patients and care providers."

Ascribe was founded by former NHS pharmacist Critchlow and Dr Chris Jones in 1984 to help healthcare professionals overcome difficulties in handling clinical information, and is a catalogue partner for some of the local service providers in the NHS in England. The company is listed on the Alternative Investment Market.

Subscribe to our newsletter

Subscribe To Our Newsletter

Subscribe To Our Newsletter

Sign up

Related News

Northern HSC Trust goes live with Clinisys Winpath

Northern HSC Trust goes live with Clinisys Winpath

Northern Health and Social Care Trust in Northern Ireland has gone live with Clinisys Winpath, the laboratory information management system.
System C acquires CIS Oncology to expand medicine management

System C acquires CIS Oncology to expand medicine management

System C has announced the strategic acquisition of CIS Oncology, marking an expansion of System C's offerings in medicines management. 
Translation tech for patients trialled in Northern Ireland

Translation tech for patients trialled in Northern Ireland

Translation tech is improving communication between staff and non-English speaking patients in the Southern Trust area of Northern Ireland.